Eniseler EB, Ekinci F, Sahbazlar M, Erdogan AP, et al. PET-derived metabolic-immunonutritional SUVmax-lactate dehydrogenase-albumin-lymphocyte index for survival prediction in human epidermal growth factor receptor 2-positive metastatic breast cancer receiving pertuzumab-based therapy. Nucl Med Commun 2026 Sep 29. doi: 10.1097/MNM.0000000000002237.
PMID: 42808915